200 related articles for article (PubMed ID: 28575522)
1. Identification of biomarker sets for predicting the efficacy of sublingual immunotherapy against pollen-induced allergic rhinitis.
Gotoh M; Kaminuma O; Nakaya A; Katayama K; Motoi Y; Watanabe N; Saeki M; Nishimura T; Kitamura N; Yamaoka K; Okubo K; Hiroi T
Int Immunol; 2017 Jun; 29(6):291-300. PubMed ID: 28575522
[TBL] [Abstract][Full Text] [Related]
2. The Relationship of Pollen Dispersal with Allergy Symptoms and Immunotherapy: Allergen Immunotherapy Improves Symptoms in the Late Period of Japanese Cedar Pollen Dispersal.
Sakurai T; Yonekura S; Iinuma T; Sakurai D; Morimoto Y; Kaneko S; Okamoto Y
Int Arch Allergy Immunol; 2018; 177(3):245-254. PubMed ID: 30021201
[TBL] [Abstract][Full Text] [Related]
3. Predictivity of clinical efficacy of sublingual immunotherapy (SLIT) based on sensitisation pattern to molecular allergens in children with allergic rhinoconjunctivitis.
di Coste A; Occasi F; De Castro G; Zicari AM; Galandrini R; Giuffrida A; Indinnimeo L; Duse M
Allergol Immunopathol (Madr); 2017; 45(5):452-456. PubMed ID: 28410874
[TBL] [Abstract][Full Text] [Related]
4. Immunological effects of sublingual immunotherapy with Japanese cedar pollen extract in patients with combined Japanese cedar and Japanese cypress pollinosis.
Kikuoka H; Kouzaki H; Matsumoto K; Arai H; Yamamoto S; Tojima I; Shimizu S; Miyashita H; Ogawa Y; Osada T; Okano M; Yuta A; Shimizu T
Clin Immunol; 2020 Jan; 210():108310. PubMed ID: 31743749
[TBL] [Abstract][Full Text] [Related]
5. Recent development on the use of sublingual immunotherapy tablets for allergic rhinitis.
Waserman S; Shah A; Avilla E
Ann Allergy Asthma Immunol; 2021 Aug; 127(2):165-175.e1. PubMed ID: 34029713
[TBL] [Abstract][Full Text] [Related]
6. Long-term sublingual immunotherapy for Japanese cedar pollinosis and the levels of IL-17A and complement components 3a and 5a.
Sakashita M; Yamada T; Imoto Y; Hirota T; Tamari M; Ito Y; Kubo S; Osawa Y; Takahashi N; Fujieda S
Cytokine; 2015 Sep; 75(1):181-5. PubMed ID: 25934649
[TBL] [Abstract][Full Text] [Related]
7. Sublingual immunotherapy alters salivary IgA and systemic immune mediators in timothy allergic children.
Huoman J; Papapavlou G; Pap A; Alm J; Nilsson LJ; Jenmalm MC
Pediatr Allergy Immunol; 2019 Aug; 30(5):522-530. PubMed ID: 30803044
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of sublingual immunotherapy for two seasons in patients with Japanese cedar pollinosis.
Okamoto Y; Okubo K; Yonekura S; Hashiguchi K; Goto M; Otsuka T; Murata T; Nakao Y; Kanazawa C; Nagakura H; Okawa T; Nakano K; Hisamitsu M; Kaneko S; Konno A
Int Arch Allergy Immunol; 2015; 166(3):177-88. PubMed ID: 25895909
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Efficacy and Dose-Finding Trial of Japanese Cedar Pollen Sublingual Immunotherapy Tablet.
Gotoh M; Yonekura S; Imai T; Kaneko S; Horikawa E; Konno A; Okamoto Y; Okubo K
J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1287-1297.e8. PubMed ID: 30537561
[TBL] [Abstract][Full Text] [Related]
10. Effect of Japanese cedar-specific sublingual immunotherapy on allergen-specific TH2 cell counts in blood.
Nomura T; Suzuki M; Yokota M; Nakamura Y; Ozeki K; Ito Y; Tsuge I; Saitoh S
Ann Allergy Asthma Immunol; 2016 Jul; 117(1):72-78.e4. PubMed ID: 27156747
[TBL] [Abstract][Full Text] [Related]
11. Long-term sublingual immunotherapy provides better effects for patients with Japanese cedar pollinosis.
Hamada S; Kobayashi Y; Sakamoto D; Shimamura A; Kuroda K; Kawachi R; Kanda A; Asako M; Gotoh M; Okubo K; Tomoda K; Iwai H
Auris Nasus Larynx; 2021 Aug; 48(4):646-652. PubMed ID: 33526319
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis.
Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Yamamoto H; Kunii N; Sakurai D; Fujimura T; Nakazawa K; Yasueda H
Int Arch Allergy Immunol; 2008; 146(1):76-84. PubMed ID: 18087165
[TBL] [Abstract][Full Text] [Related]
13. An analysis of factors related to the effect of sublingual immunotherapy on Japanese cedar pollen induced allergic rhinitis.
Yonekura S; Okamoto Y; Sakurai D; Okubo K; Gotoh M; Kaneko S; Konno A
Allergol Int; 2018 Apr; 67(2):201-208. PubMed ID: 28760534
[TBL] [Abstract][Full Text] [Related]
14. Immunological parameters in prophylactic sublingual immunotherapy in asymptomatic subjects sensitized to Japanese cedar pollen.
Yamanaka K; Shah SA; Sakaida H; Yamagiwa A; Masuda S; Mizutani H; Takeuchi K
Allergol Int; 2015 Jan; 64(1):54-9. PubMed ID: 25605528
[TBL] [Abstract][Full Text] [Related]
15. Safety evaluation of standardized allergen extract of Japanese cedar pollen for sublingual immunotherapy.
Mitobe Y; Yokomoto Y; Ohashi-Doi K
Regul Toxicol Pharmacol; 2015 Apr; 71(3):529-40. PubMed ID: 25701184
[TBL] [Abstract][Full Text] [Related]
16. Long-term treatment of Japanese cedar pollinosis with Japanese cedar pollen SLIT drops and persistence of treatment effect: A post-marketing clinical trial.
Nomura Y; Okubo K; Nakamura T; Sawaki S; Kitagou H; Idei N; Kaneko S; Kobayashi S; Tanaka Y; Okamoto Y
Allergol Int; 2021 Jan; 70(1):96-104. PubMed ID: 32653209
[TBL] [Abstract][Full Text] [Related]
17. Japanese cedar pollen sublingual immunotherapy is effective in treating seasonal allergic rhinitis during the pollen dispersal period for Japanese cedar and Japanese cypress.
Yonekura S; Gotoh M; Okano M; Kurokawa T; Maekawa Y; Okubo K; Okamoto Y
Allergol Int; 2022 Jan; 71(1):140-143. PubMed ID: 34509370
[No Abstract] [Full Text] [Related]
18. The Efficacy of Sublingual Immunotherapy for Allergic Rhinitis May Vary with the Time of Day.
Igarashi S; Suzuki K; Nakamura Y; Ishimaru K; Fukano C; Masuyama K; Ohashi-Doi K; Nakao A
Int Arch Allergy Immunol; 2016; 171(2):111-118. PubMed ID: 27902978
[TBL] [Abstract][Full Text] [Related]
19. Dose-finding study of carbamylated monomeric allergoid tablets in grass-allergic rhinoconjunctivitis patients.
Mösges R; Rohdenburg C; Eichel A; Zadoyan G; Kasche EM; Shah-Hosseini K; Lehmacher W; Schmalz P; Compalati E
Immunotherapy; 2017 Nov; 9(15):1225-1238. PubMed ID: 29130797
[TBL] [Abstract][Full Text] [Related]
20. Decreased level of osteopontin in children with allergic rhinitis during sublingual immunotherapy.
Wang C; Wang K; Liu S; Qin X; Chen K; Zhang T
Int J Pediatr Otorhinolaryngol; 2016 Feb; 81():15-20. PubMed ID: 26810282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
